Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

NeoStem agrees stem cell collection centre deal

NeoStem : 28 May, 2008  (Company News)
NeoStem, a pioneer of pre-disease collection, processing and long-term storage of adult stem cells for future medical needs, has signed a collection centre agreement with the University of Louisville Hospital/ James Graham Brown Cancer Center.
Robin Smith, MD MBA, NeoStem's chairman and chief executive officer commented: 'This is an extraordinary agreement for NeoStem and University of Louisville that will allow us to move adult stem cell therapies forward, both at the basic science and translational level.'

NeoStem acquired the exclusive worldwide rights to Very Small Embryonic-Like (VSEL) Stem Cell technology developed by researchers at the University of Louisville in November 2007. VSELs have been identified in adult bone marrow and resemble embryonic stem cells both morphologically and transcriptionally.

Although early stage technology, the company expects VSELS to serve as the basis for its entry into the therapeutic market place. VSELs have the ability to grow in the laboratory and multiply into clusters of cells that then can differentiate into specialised cells found in different types of tissue including cardiac, neural, endothelial, muscle, pancreatic and haematopoietic cells. However, unlike controversial embryonic stem cells, VSELs can be harvested from adult peripheral blood. These naturally occurring regenerative cells may have the potential to be used for future therapeutic repair of degenerative, diseased or damaged tissue.

'The Louisville collection centre represents a unique opportunity for University of Louisville,' added Manuel Martinez, MD, executive vice president for research, University of Louisville. 'There are a number of adult stem cell translational scientists and clinicians at the university that are interested in exploring the therapeutic potential of VSELs and other adult stem cells of the body. The collection centre will allow harvesting large numbers of these cells from adults donating them for basic research as well as clients paying to have their cells stored for their own future medical need.'

'By enabling investigators to have access to large numbers of adult stem cells from interested and informed study subjects, we believe that translational adult stem cell research will move forward at an accelerated pace and that clinical trial designs will be more rapidly implemented to investigate new research findings. Overall, we anticipate that this corporate and academic relationship will assist in propelling the adult stem cell field forward. This will allow NeoStem to take the lead in harnessing and translating this revolutionary and promising new approach to treat human disease.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo